These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Opioid reinforcement in heroin-dependent volunteers during outpatient buprenorphine maintenance. Greenwald MK; Johanson CE; Schuster CR Drug Alcohol Depend; 1999 Oct; 56(3):191-203. PubMed ID: 10529021 [TBL] [Abstract][Full Text] [Related]
14. Buprenorphine/Naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder. Becker WC; Ganoczy D; Fiellin DA; Bohnert AS J Subst Abuse Treat; 2015 Jan; 48(1):128-31. PubMed ID: 25312475 [TBL] [Abstract][Full Text] [Related]
15. Buprenorphine-naloxone Versus Buprenorphine for Treatment of Opioid Use Disorder in Pregnancy. Perry BN; Vais S; Boateng JO; Jain M; Wachman EM; Saia KA J Addict Med; 2022 Nov-Dec 01; 16(6):e399-e404. PubMed ID: 35916423 [TBL] [Abstract][Full Text] [Related]
16. Effects of an alternative reinforcer on intravenous heroin self-administration by humans. Comer SD; Collins ED; Wilson ST; Donovan MR; Foltin RW; Fischman MW Eur J Pharmacol; 1998 Mar; 345(1):13-26. PubMed ID: 9593589 [TBL] [Abstract][Full Text] [Related]
17. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726 [TBL] [Abstract][Full Text] [Related]
18. Buprenorphine/naloxone treatment practices in Malaysia: Results of national surveys of physicians and patients. Vicknasingam B; Dazali MN; Singh D; Schottenfeld RS; Chawarski MC Drug Alcohol Depend; 2015 Jul; 152():164-9. PubMed ID: 25935736 [TBL] [Abstract][Full Text] [Related]
19. An open-label study of a functional opioid kappa antagonist in the treatment of opioid dependence. Rothman RB; Gorelick DA; Heishman SJ; Eichmiller PR; Hill BH; Norbeck J; Liberto JG J Subst Abuse Treat; 2000 Apr; 18(3):277-81. PubMed ID: 10742642 [TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of long-term outpatient buprenorphine-naloxone treatment for opioid dependence in primary care. Schackman BR; Leff JA; Polsky D; Moore BA; Fiellin DA J Gen Intern Med; 2012 Jun; 27(6):669-76. PubMed ID: 22215271 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]